Amarna Therapeutics

Amarna Therapeutics is at the forefront of pharmaceutical manufacturing, pioneering the development of transformative gene therapies with the potential to cure a wide range of rare and prevalent diseases. Located at J.H. Oortweg 21 in Leiden, 2333CH, NL, Amarna Therapeutics is dedicated to unlocking the full potential of gene therapy and expanding its boundaries.

Amarna Therapeutics has developed a unique, fully-integrated gene therapy platform that delivers transgenes without eliciting immune responses, ensuring safe, effective, and durable therapeutic outcomes. With its proprietary production cell line, SuperVero™, and its genetically engineered SVec viral vector, Amarna Therapeutics is uniquely positioned to address genetic disorders, autoimmune diseases, and chronic inflammation.

With headquarters in Leiden Bio Science Park, Netherlands, Amarna Therapeutics is committed to advancing the field of gene therapy and improving patient lives worldwide. Information about Amarna Therapeutics will be completed soon with the support of the company’s management. We invite the manager of Amarna Therapeutics to create a customized and exclusive company showcase and product listing on our platform.